Association of chronic thromboembolic pulmonary hypertension with hereditary and acquired risk factors for thromboembolism.
AbstractThrombophilia increases the incidence of pulmonary thrombosis significantly. Various hereditary and acquired factors are known for thromboembolism. The hereditary factors are two common genetic autosomal mutations including factor V leidan mutation and prothrombin gene mutation. A descriptive- analytical design was conducted on 60 patients with thromboembolism who met the inclusion criteria. Two groups with hereditary and acquired risk factors for thromboembolism (group A, B, each 30 people) were evaluated. All the patients of two groups were evaluated in terms of emboli associated with hereditary and acquired risk factors. Association of thromboembolism risk factors' with pulmonary hypertension were studied at the beginning of the study and six months after the treatment then the results of two groups were compared. Among participants, 31 (56.4%) were men. The mean age of the patients was 44.4±14 years, ranging between 23-75 years. Significant association was observed between the stability of the blood clot in pulmonary vessel, six months after the treatment with genetic risk factors (P=0.03). However, no significant association was between pulmonary hypertension and hereditary and acquired risk factors (P=0.24). Based on the significant association between the hereditary risk factors and pulmonary emboli, by taking special prevention and therapy measurements (e.g. genetic engineering), some pulmonary and mortality complications can be prevented and the patient himself and health care system would benefit from this issue.
Auger WR, Kim NH, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2007;28(1):255-69.
Bonderman D1, Jakowitsch J, Adlbrecht C, et al., Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005;93(3):512-6.
Kluetz PG, White CS. Acute pulmonary embolism: imaging in the emergency department. Radiol Clin North Am 2006;44(2):259-71.
Lang I, Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3(7):568-70.
Masotti L, Righini M, Vuilleumier N, et al., Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers. Vasc Health Risk Manag 2009;5(4):567-75.
Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000;160(2):159-64.
Pengo V, Lensing AW, Prins MH, et al., Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. New Engl J Med 2004;350(22):2257-64.
Qanadli SD, El Hajjam M, Vieillard-Baron A, et al. New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol 2001;176(6):1415-20.
Qaseem A, Snow V, Barry P, et al. Current Diagnosis of= Venous Thromboembolism in Primary Care: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2007;146(6):454-8.
Wu AS, Pezzullo JA, Cronan JJ, et al., CT Pulmonary Angiography: Quantification of Pulmonary Embolus as a Predictor of Patient Outcome—Initial Experience1. Radiology 2004;230(3):831-5.